Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
Recruiting · NCT05361837 · Interventional (participants receive a specific treatment) · Lead sponsor: National Cancer Institute, Egypt
View the official record on ClinicalTrials.gov →Interventions studied
Bilevel serratus anterior plane blockBilevel serratus anterior plane block with dexmedetomidineSingle level serratus anterior plane blockSingle level serratus anterior plane block with dexmedetomidine
What this trial is about
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
Who can take part
Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- patients scheduled for modified radical mastectomy,
- Age 18-65 years,
- ASA I-II
Exclusion criteria
- patient refusal,
- coagulation defects,
- abnormal kidney or liver functions,
- local infection at site of injection.
Where it is running
1 location listed.
- Walaa Y Elsabeeny - Cairo, Cairo Governorate, Egypt